Heart Disease News and Research

Latest Heart Disease News and Research

Tea and coffee can reduce risk of type 2 diabetes

Drinking more coffee (regular or decaffeinated) or tea appears to lower the risk of developing type 2 diabetes, according to an analysis of previous studies reported in the December 14/28 issue of Archives of Internal Medicine, JAMA.

14 Dec 2009

ZYPREXA RELPREVV approved by FDA

The U.S. Food and Drug Administration (FDA) approved ZYPREXA RELPREVV (olanzapine) For Extended Release Injectable Suspension for the treatment of schizophrenia in adults, Eli Lilly and Company announced today.

14 Dec 2009

Montreal Heart Institute performs landmark procedure

The electrophysiology team at the Montreal Heart Institute (MHI) recently performed the first implantation of a new type of cardiac pacemaker (Accent RF(TM)) in Canada.

14 Dec 2009

MHI launches new research program in heart failure

The Montreal Heart Institute (MHI) and its Foundation (MHIF) launched today the Carolyn and Richard J. Renaud Research Chair in Heart Failure, the first of its kind in Québec.

14 Dec 2009

Genentech announces Phase III study of Avastin in women treated with chemotherapy for advanced breast cancer

Genentech, Inc., a wholly owned member of the Roche Group, today announced results from a Phase III study (RIBBON 2) of Avastin® (bevacizumab) in women who had previously been treated with initial (first-line) chemotherapy for advanced HER2-negative breast cancer and needed additional (second-line) treatment.

14 Dec 2009

Eggs of marine animals is the best dietary source of Omega 3 fatty acids

The roe of hake, lumpsucker and salmon is the best dietary source of Omega 3, according to a study carried out by researchers at the University of Almer-a (UAL). The scientists analysed the eggs, or roe, of 15 marine animals, and found all of these contained high levels of these fatty acids, which are essential to the human body.

14 Dec 2009

Several DNA sequences linked to impaired pulmonary function, uncovers new study

A new study involving data from more than 20,000 individuals has uncovered several DNA sequences linked to impaired pulmonary function. The research, an analysis that combined the results of several smaller studies, provides insight into the mechanisms involved in reaching full lung capacity.

14 Dec 2009

Changes to NCQA's disease management Accreditation and Certification standards released

The National Committee for Quality Assurance (NCQA) today released changes to its disease management Accreditation and Certification requirements, adding voluntary performance reporting for five chronic conditions.

14 Dec 2009

Pfizer announces results from studies evaluating neratinib

Pfizer Inc. today announced results from studies evaluating neratinib (HKI-272), an investigational, orally administered, pan-ErbB inhibitor, in patients with human epidermal growth factor receptor-2 (HER2, also known as ErbB2) positive breast cancer at the 2009 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).

14 Dec 2009

Senator Arlen Specter proposes new amendment to current healthcare reform bill

Senator Arlen Specter (D-PA) today proposed a new amendment to the current healthcare reform bill which will preserve access to care for millions of Medicare patients seen by a medical specialist.

14 Dec 2009

Results from Phase 2 trial evaluating Nexavar with capecitabine and paclitaxel presented

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced results from two collaborative group-sponsored randomized, double-blind, placebo-controlled Phase 2 trials were presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS).

14 Dec 2009

Heart attacks peak during winter months, finds research

Research has found that heart attacks peak during the winter months, and the prevailing hypothesis has been that cold temperatures stress the heart. But in 2004, researchers analyzed 12 years of Los Angeles County death certificates and found that heart attack deaths also rise in the balmy Los Angeles winters.

14 Dec 2009

Combination therapy improves overall survival in women with advanced breast cancer

In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® (trastuzumab). The results of the Phase III study in HER2-positive metastatic breast cancer were presented during the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held in San Antonio, Texas (Dec. 9 - 13).

14 Dec 2009

Study: Ethyl nitrite improves blood flow and organ status during laparoscopy

As good as laparoscopy is in preventing some of the stresses of open surgery on the body, it does have drawbacks, including reduced blood flow and organ dysfunction. Laparoscopy is a type of surgery in the abdomen done through small incisions.

14 Dec 2009

National Vaccine Plan aims to protect Americans from vaccine-preventable illnesses

While vaccines help prevent many diseases in the United States, we lack immunization protection against several serious illnesses, says a new report from the Institute of Medicine that identifies priority areas for updating the National Vaccine Plan.

14 Dec 2009

Study finds widespread variations in CRT use for patients with severe heart failure

Most patients with heart failure likely to benefit from a pacemaker including the capacity for cardiac resynchronization therapy (CRT) do not receive such an implantable device, reports a national study in the December 2009 issue of the American Heart Journal.

14 Dec 2009

NIST and PTB join to test newly developed optical magnetic field sensor

The "magnetically best shielded room on earth" has the size of an apartment block and is located on the site of the Physikalisch-Technische Bundesanstalt (PTB), Institute Berlin. Magnetic fields such as that of the earth are kept out here as effective as nowhere else.

14 Dec 2009

Heart Disease News and Research

Latest Heart Disease News and Research

Tea and coffee can reduce risk of type 2 diabetes

ZYPREXA RELPREVV approved by FDA

Montreal Heart Institute performs landmark procedure

MHI launches new research program in heart failure

Genentech announces Phase III study of Avastin in women treated with chemotherapy for advanced breast cancer

Eggs of marine animals is the best dietary source of Omega 3 fatty acids

Several DNA sequences linked to impaired pulmonary function, uncovers new study

Changes to NCQA's disease management Accreditation and Certification standards released

Pfizer announces results from studies evaluating neratinib

Senator Arlen Specter proposes new amendment to current healthcare reform bill

Results from Phase 2 trial evaluating Nexavar with capecitabine and paclitaxel presented

Heart attacks peak during winter months, finds research

Combination therapy improves overall survival in women with advanced breast cancer

Study: Ethyl nitrite improves blood flow and organ status during laparoscopy

National Vaccine Plan aims to protect Americans from vaccine-preventable illnesses

Study finds widespread variations in CRT use for patients with severe heart failure

NIST and PTB join to test newly developed optical magnetic field sensor

VNA of Greater Philadelphia expands its home health and specialty services in Bucks County

Patients with elevated CRP and normal LDL levels may benefit from statin therapy

Incyte announces positive results from ongoing Phase I/II clinical trial for INCB7839

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in